Zweig-DiMenna Associates’s RenaissanceRe RNR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-46,400
Closed -$11.1M 97
2025
Q1
$11.1M Buy
+46,400
New +$11.2M 1.76% 20
2024
Q2
Sell
-98,478
Closed -$23.1M 120
2024
Q1
$23.1M Hold
98,478
2.02% 11
2023
Q4
$19.3M Sell
98,478
-29,982
-23% -$6.23M 2.18% 11
2023
Q3
$25.4M Buy
128,460
+300
+0.2% +$57.7K 3.01% 5
2023
Q2
$23.9M Buy
128,160
+46,510
+57% +$9.25M 2.99% 7
2023
Q1
$16.4M Buy
81,650
+17,600
+27% +$3.54M 2.21% 12
2022
Q4
$11.8M Buy
64,050
+44,550
+228% +$7.51M 1.72% 17
2022
Q3
$2.74M Buy
+19,500
New +$2.71M 0.6% 58
2020
Q4
Sell
-48,034
Closed -$8.15M 169
2020
Q3
$8.15M Sell
48,034
-18,500
-28% -$3.27M 0.55% 67
2020
Q2
$11.4M Buy
+66,534
New +$10.9M 1.2% 32
2020
Q1
Sell
-55,500
Closed -$10.9M 102
2019
Q4
$10.9M Buy
+55,500
New +$10.5M 1.09% 34
2014
Q3
Sell
-2,600
Closed -$278K 314
2014
Q2
$278K Buy
+2,600
New +$266K 0.01% 173
2014
Q1
Sell
-2,700
Closed -$263K 287
2013
Q4
$263K Buy
+2,700
New +$252K 0.01% 167
2013
Q3
Sell
-4,164
Closed -$361K 263
2013
Q2
$361K Buy
+4,164
New +$369K 0.01% 175

Other funds holding RNR

Zweig-DiMenna Associates's RNR Position: Q2 2025 in Review

Zweig-DiMenna Associates sold out of RenaissanceRe (RNR) in Q2 2025, closing a stake of 46,400 shares — an estimated $11.1M sold.

Zweig-DiMenna Associates first reported a position in RNR in Q2 2013 and held it in 14 quarters. The position peaked at $25.4M in Q3 2023. 489 funds tracked by Wall St. Rank hold RNR as of Q2 2025.

  • Zweig-DiMenna Associates reported no remaining RenaissanceRe position as of Q2 2025 after selling out during the quarter.
  • Zweig-DiMenna Associates sold 46,400 RenaissanceRe shares in Q2 2025, an estimated $11.1M.
  • Zweig-DiMenna Associates first reported a position in RenaissanceRe in Q2 2013 and held it in 14 quarters.
  • Zweig-DiMenna Associates's RenaissanceRe position peaked at $25.4M in Q3 2023.
  • 489 funds tracked by Wall St. Rank held RenaissanceRe as of Q2 2025.

Based on Zweig-DiMenna Associates's 13F filing for Q2 2025, filed 5 Aug 2025.